Back to News
Market Impact: 0.15
Revolution Medicines (BMV:RVMD) Consensus Price Target Increased by 30.66% to MX$3,921.29
Source: Nasdaq
Analyst EstimatesCompany Fundamentals
Revolution Medicines’ average 1-year price target was raised to MX$3,921.29 per share, up 30.66% from the prior MX$3,001.13 target (dated Aug. 3, 2026). The update reflects a higher consensus view from multiple analyst targets and is likely to be modest near-term given no additional operating or clinical catalysts were cited.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
RVMD0.35
More News
- Costco Wholesale Has Fallen More Than 10% From Its Peak Before. Here's What History Says Happens Next.
- Ember’s new temperature-controlled mug makes my nightly tea ritual even better
- Get Help With Holiday Spending: Best Credit Card Bonuses This Week, Oct. 17, 2026
- Bending Spoons wants to revive software castoffs. Berkshire is backing the plan
- ‘How many canaries have we killed in the coal mine?’ — Wall Street debates if the latest AI bubble warnings are another head fake or the real thing
- Alphabet’s chief investment officer responds to Jefferies warning that the most likely outcome of the AI boom is massive U.S. capital destruction